Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures, as well as non-pharmacological treatment of gastroesophageal reflux disease. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Merit Medical Systems Inc.

Barrington analyst Michael Petusky maintained a Buy rating on Merit Medical Systems today and set a price target of $106.00. According to TipRanks,...

Barrington Reaffirms Their Buy Rating on Merit Medical Systems (MMSI)

In a report released today, John Young CFA from Canaccord Genuity maintained a Buy rating on Merit Medical Systems, with a price target of $93.00. ...

Canaccord Genuity Sticks to Their Buy Rating for Merit Medical Systems (MMSI)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Stryker (SYK – Research Report), HeartBeam (BEAT – R...

Analysts’ Top Healthcare Picks: Stryker (SYK), HeartBeam (BEAT)

An announcement from Merit Medical Systems ( ($MMSI) ) is now available. Merit Medical Systems announced on November 13, 2025, that the U.S. Center...

Current Quarter	$0.84	Next Quarter	$0.78
Current Year	$3.25	Next Year	$3.57
QoQ Growth	-7.1%	YoY Growth	+9.8%
3Y EPS CAGR	+34.0%	Target Price	$102.50
Consensus	Buy	Upside	+23.3%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MMSI	$83.13	-0.36%	177.64K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MMSI	$83.13	-0.4%	177.64K
3
4
5
6

MMSI

MMSI

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Merit Medical Systems Inc. Data in Excel

Get Merit Medical Systems Inc. Data in Excel